Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desidustat for renal anemia in non-dialysis CKD (Phase III, China)
ChiCTR2100052908Phase 3Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anemia of renal disease and chronic kidney disease (CKD) comparing Desidustat → open-label Desidustat with Placebo → open-label Desidustat (2 arms). Primary endpoint: Change in mean hemoglobin concentration. Started Dec 2021; status: recruiting.
02
Drugs
desidustat
03
Conditions
anemia of renal diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2100052908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052908.